NXGL - NEXGEL, INC.

2.66
0.040   1.504%

Share volume: 48,228
Last Updated: 04-09-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 0.17%

PREVIOUS CLOSE
CHG
CHG%
$2.62
0.04
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
15%
Profitability 0%
Dept financing 24%
Liquidity 38%
Performance 21%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.14%
1 Month
-5.67%
3 Months
-21.53%
6 Months
-6.67%
1 Year
24.30%
2 Year
90.00%
Key data
Stock price
$2.66
P/E Ratio 
0.00
DAY RANGE
$2.46 - $2.79
EPS 
-$0.25
52 WEEK RANGE
$1.84 - $5.10
52 WEEK CHANGE
$20.36
MARKET CAP 
30.287 M
YIELD 
N/A
SHARES OUTSTANDING 
6.324 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-12-2025
BETA 
0.82
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$47,182
AVERAGE 30 VOLUME 
$43,729
Company detail
CEO: Adam D. Levy
Region: US
Website: nexgel.com
Employees: 10
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded in 1997 and is based in Langhorne, Pennsylvania.

Recent news
loading